BioLine RX News

News

Ticker

BLRX.TA

ISIN

IL0011015182

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

BioLine RX Eulerpool News

BioLine RX Stock News

BioLine RX is being monitored by journalists and investors worldwide. We gather the latest BioLine RX news here.

March 20 ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
February 26 ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23 ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
November 29 ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
November 25 ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
November 24 ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 24 ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
November 18 ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
November 17 ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
September 30 ·
Yahoo
BLRX: A Venture into GBM
September 29 ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Investor Call (Transcript)
September 29 ·
SeekingAlpha
BioLineRx Ltd. - Special Call
August 14 ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
August 14 ·
Benzinga
Earnings Scheduled For August 14, 2025
July 3 ·
Yahoo
H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. (BLRX) After ASCO 2025
June 17 ·
Benzinga
Where BioLine Rx Stands With Analysts
June 9 ·
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 31 ·
Yahoo
BioLineRx upgraded to Buy from Hold at JonesResearch
May 30 ·
Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
May 30 ·
Yahoo
BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting

BioLine RX Stock Press Releases

BioLine RX regularly publishes news on the company's website that are relevant for investors.

November 18 •
BioLine RX
Biolinerx Reports Third Quarter 2021 Financial Results And Provides Corporate Update
August 18 •
BioLine RX
BioLine RX Reports Q2 Loss Per Share Of $0.01
May 26 •
BioLine RX
Biolinerx Reports Q1 2021 Financial Results
May 4 •
BioLine RX
Biolinerx Announces Positive Top-Line Results From Genesis Phase 3 Trial Of Motixafortide In Stem-Cell Mobilization For Autologous Bone Marrow Transplantation In Multiple Myeloma Patients
February 23 •
BioLine RX
Biolinerx Reports Year-End 2020 Financial Results
January 19 •
BioLine RX
Biolinerx Announces $10 Million Bought Deal Offering
December 16 •
BioLine RX
Biolinerx Announces Final Results From Phase 2A Combat/Keynote-202 Triple Combination Study Of Motixafortide
November 23 •
BioLine RX
BioLineRx Reports Q3 Loss Per Share $0.02
November 18 •
BioLine RX
BiolineRx Announces Initiation Of Phase 1B Clinical Trial In Patients With Acute Respiratory Distress Syndrome Secondary To COVID-19 And Other Respiratory Viral Infections
October 30 •
BioLine RX
Biolinerx Announces Positive Results From Interim Analysis Of Genesis Phase 3 Trial Of Motixafortide In Stem Cell Mobilization
August 6 •
BioLine RX
BioLineRx Says On Track To Report Three Significant Data Readouts In Next Few Months
May 20 •
BioLine RX
Bioline Rx Ltd Reports Q1 Loss Per Share Of $0.04
March 12 •
BioLine RX
Bioline On Track To Report Data From Triple Combination Arm Of Ongoing Mid-stage Trial In Mid-2020

BioLine RX News 2026

This page contains all current news, analysis and press releases for BioLine RX stock (BLRX.TA, ISIN: IL0011015182). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at BioLine RX.

BioLine RX Stock

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.